Stephen Davis
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Acadia Pharmaceuticals Inc (ACAD) | — | $822,316 | $14,028,139 |
| 2021 | Acadia Pharmaceuticals Inc (ACAD) | — | $792,831 | $9,793,289 |
| 2020 | Acadia Pharmaceuticals Inc (ACAD) | — | $767,624 | $7,763,187 |
| 2019 | Acadia Pharmaceuticals Inc (ACAD) | — | $743,705 | $7,631,245 |
| 2018 | Acadia Pharmaceuticals Inc (ACAD) | — | $719,833 | $6,508,032 |
Earnings-call appearances
-
Acadia Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-02
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-08
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2022 Earnings Call2022-05-04
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q4 FY2021 Earnings Call2022-02-28
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q3 FY2021 Earnings Call2021-11-08
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2021 Earnings Call2021-08-04
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-05
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2020 Earnings Call2020-08-05
Acadia Pharmaceuticals Inc (ACAD)